Skip to main content

Day: November 5, 2025

Badger Infrastructure Delivers Another Quarter of Double Digit Growth in Revenue, Adjusted EBITDA and Adjusted Net Earnings

CALGARY, Alberta, Nov. 05, 2025 (GLOBE NEWSWIRE) — Badger Infrastructure Solutions Ltd. (“Badger”, the “Company”, “we”, “our” or “us”) (TSX:BDGI) reported third quarter results today. All results are presented in U.S. dollars unless otherwise stated. 2025 THIRD QUARTER OPERATIONAL HIGHLIGHTSRevenue was $237.3 million, up 13% from $209.4 million in 2024. Gross profit margin was 32.6%, up from 32.5% in 2024. Adjusted EBITDA(1) improved to $66.8 million, up 15% from $58.3 million in 2024. Adjusted EBITDA margin(1) rose to 28.2%, up from 27.8% in 2024. Revenue per truck per month (“RPT”)(1) was $47,921, compared to $44,297 in 2024. Adjusted net earnings per share(1) was $0.91, up 25% from $0.73 in 2024. The Company’s board of directors has approved a quarterly cash dividend of CAD$0.1875 per common share for the fourth fiscal...

Continue reading

Itafos Reports Outstanding Q3 2025 Performance and Mechanical Completion of the H1/NDR Mine

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (the “Company”) today reported its Q3 2025 financial results and provided a corporate update. The Company’s financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2025 are available under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.itafos.com. All figures are in thousands of US Dollars except as otherwise noted. A recorded webcast of management’s commentary reviewing the Q3 2025 financial results and an update on the business will be available on the Company’s website on Monday, November 10, 2025 (see details below). CEO Commentary Chief Executive Officer, David Delaney commented, “we are pleased to report another highly successful quarter in which the Company...

Continue reading

Slide Announces Third Quarter 2025 Results

TAMPA, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — Slide Insurance Holdings, Inc. (“Slide”) (Nasdaq: SLDE) today announced financial results for the third quarter 2025. Slide’s third quarter financial results and management commentary can be found in the shareholder letter posted to the Company’s investor relations website. Slide will hold a conference call to discuss financial results today, November 5, at 5 pm Eastern Time. The dial-in number for the conference call is (877) 407-9208 (toll-free) or (201) 493-6784 (international). Please dial the number 10 minutes prior to the scheduled start time. A live webcast of the conference call will also be available at ir.slideinsurance.com. A webcast replay of the call will be available at ir.slideinsurance.com for one year following the call. About Slide Slide is a technology-enabled insurance...

Continue reading

National Healthcare Properties Reports Third Quarter 2025 Results

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on seniors housing and outpatient medical facilities, today announced results for the three and nine months ended September 30, 2025. Michael Anderson, Chief Executive Officer and President, commented, “We are very pleased with the continued strong momentum of our business across-the-board in the third quarter. The exceptional growth of same store cash net operating income within the Senior Housing Operating Property segment and the continued durable performance of the Outpatient Medical Facility segment are laying a solid foundation for our public listing preparation.” Financial Performance and Other HighlightsNet loss of $(0.56) per...

Continue reading

Carriage Services Announces Strong Third Quarter Results and Confirms the Midpoint of the 2025 Outlook 

Conference call on Thursday, November 6, 2025 at 8:00 a.m. Central Time HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced its financial results for the third quarter ended September 30, 2025. Company Highlights:Total revenue grew 2.0% over the prior year quarter, driven by increased operating revenue of 5.2% primarily as a result of 21.4% growth in cemetery preneed sales; Cemetery operating revenue increased 12.6% over the prior year quarter, driven by a 4.6% increase in the number of preneed interment rights sold and a 15.1% increase in the average price of preneed interment rights sold; Financial revenue increased 27.2% over the prior year quarter, primarily driven by a 27.9% increase in preneed insurance contracts sold resulting in an increase in general agency commission revenue; GAAP...

Continue reading

National Fuel Reports Fourth Quarter and Full Year Fiscal 2025 Earnings

WILLIAMSVILLE, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) — National Fuel Gas Company (“National Fuel” or the “Company”) (NYSE:NFG) today announced consolidated results for the three months and fiscal year ended September 30, 2025. FOURTH QUARTER FISCAL 2025 SUMMARYGAAP earnings per share of $1.18 compared to a net loss of $1.84 per share in the prior year. Adjusted earnings per share of $1.22, an increase of 58%, compared to $0.77 per share in the prior year. See non-GAAP reconciliation on page 2. Announced the acquisition of CenterPoint Energy’s Ohio natural gas utility for $2.62 billion, which is expected to double Utility segment rate base and is targeted to close in the fourth quarter of calendar 2026. Supply Corporation filed an application with FERC for its Shippingport Lateral Project, an interstate pipeline expansion...

Continue reading

W&T Offshore Announces Third Quarter 2025 Results and Declares Dividend for Fourth Quarter of 2025

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T,” the “Company,” “we” or “us”) today reported operational and financial results for the third quarter of 2025 and declared a fourth quarter 2025 dividend of $0.01 per share. This press release includes non-GAAP financial measures, including Adjusted Net Loss, Adjusted EBITDA, Free Cash Flow and Net Debt, which are described and reconciled to the most comparable GAAP measures in the accompanying tables to this press release under “Non-GAAP Information.” Key highlights for the third quarter of 2025 and through the date of this press release include:Increased production to 35.6 thousand barrels of oil equivalent per day (“MBoe/d”) (49% liquids), near the high end of guidance; Reduced lease operating expenses (“LOE”) per barrel of oil equivalent...

Continue reading

PharmaCorp Announces C$15 Million Bought Deal Public Offering

The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 05, 2025 (GLOBE NEWSWIRE) — PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) co-led by Canaccord Genuity Corp. and Acumen Capital Finance Partners Limited pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 35.7 million units (the “Units”) in the capital of the Company at a price of C$0.42 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of C$15.0 million (the “Offering”). Each Unit shall...

Continue reading

SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update

SCYNEXIS to receive one-time payments totalling $24.8 million from GSK as part of the resolution of the disagreement related to the restart of the Phase 3 MARIO study in invasive candidiasis. Scynexis agreed to GSK’s request to terminate the study.Following the positive SAD/MAD data results announced in September for SCY-247, its second-generation fungerp, the Company expects to initiate a Phase 1 study with the IV formulation and a Phase 2 study for the treatment of invasive candidiasis. The Company aims to release clinical proof of concept data in invasive candidiasis in 2026 and is exploring non-dilutive funding opportunities to support the development of SCY-247.GSK remains committed to the relaunch of BREXAFEMME® with activities ongoing to transfer the NDA before the end of the year. Following the relaunch, SCYNEXIS stands to...

Continue reading

Genco Shipping & Trading Limited Announces Q3 2025 Financial Results

Declares Dividend of $0.15 per share for Q3 2025Represents Genco’s 25th Consecutive Quarterly Dividend NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today reported its financial results for the three months and nine months ended September 30, 2025. Third Quarter 2025 and Year-to-Date HighlightsDividendDeclared a $0.15 per share dividend for Q3 2025 25th consecutive quarterly dividendCumulative dividends of $7.065 per share or approximately 43% of our current share price1Q3 2025 dividend is payable on or about November 24, 2025 to all shareholders of record as of November 17, 2025GrowthAcquired the Genco Courageous, a high specification 2020-built...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.